Emmanuelle Bourbouloux

2.1k total citations
43 papers, 904 citations indexed

About

Emmanuelle Bourbouloux is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emmanuelle Bourbouloux has authored 43 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emmanuelle Bourbouloux's work include Cancer Treatment and Pharmacology (14 papers), Advanced Breast Cancer Therapies (8 papers) and HER2/EGFR in Cancer Research (7 papers). Emmanuelle Bourbouloux is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Advanced Breast Cancer Therapies (8 papers) and HER2/EGFR in Cancer Research (7 papers). Emmanuelle Bourbouloux collaborates with scholars based in France, United Kingdom and Italy. Emmanuelle Bourbouloux's co-authors include Mario Campone, L. Campion, Caroline Rousseau, B. Bridji, I. Resche, Jean‐Sébastien Frenel, J. F. Chatal, Dominique Berton-Rigaud, Christine Sagan and Pierre Kerbrat and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Emmanuelle Bourbouloux

42 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle Bourbouloux France 14 345 238 232 213 184 43 904
Marco Johannes Battista Germany 18 426 1.2× 128 0.5× 205 0.9× 245 1.2× 154 0.8× 76 998
Toshiaki Saeki Japan 16 441 1.3× 192 0.8× 180 0.8× 312 1.5× 180 1.0× 43 1.0k
Martin Zweifel Switzerland 17 229 0.7× 146 0.6× 168 0.7× 341 1.6× 119 0.6× 37 987
André T. Brunetto Brazil 20 451 1.3× 77 0.3× 174 0.8× 515 2.4× 266 1.4× 58 1.2k
Jolanta Krajewska Poland 22 317 0.9× 146 0.6× 162 0.7× 366 1.7× 197 1.1× 90 1.6k
Zhong‐Ling Qiu China 22 299 0.9× 275 1.2× 187 0.8× 262 1.2× 228 1.2× 70 1.3k
Martin Werner Germany 12 252 0.7× 89 0.4× 192 0.8× 319 1.5× 179 1.0× 21 837
R. Molina Spain 9 299 0.9× 108 0.5× 240 1.0× 251 1.2× 163 0.9× 16 689
Laura Pizzuti Italy 23 906 2.6× 119 0.5× 410 1.8× 454 2.1× 333 1.8× 96 1.7k
M de Latour France 18 431 1.2× 207 0.9× 458 2.0× 282 1.3× 133 0.7× 48 1.2k

Countries citing papers authored by Emmanuelle Bourbouloux

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Bourbouloux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Bourbouloux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Bourbouloux more than expected).

Fields of papers citing papers by Emmanuelle Bourbouloux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Bourbouloux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Bourbouloux. The network helps show where Emmanuelle Bourbouloux may publish in the future.

Co-authorship network of co-authors of Emmanuelle Bourbouloux

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Bourbouloux. A scholar is included among the top collaborators of Emmanuelle Bourbouloux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Bourbouloux. Emmanuelle Bourbouloux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grellety, Thomas, Carine Bellera, Coralie Cantarel, et al.. (2025). Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study. Journal of Geriatric Oncology. 102812–102812.
2.
Robert, Marie, et al.. (2023). Evaluating everolimus for the treatment of breast cancer. Expert Opinion on Pharmacotherapy. 24(10). 1105–1111. 11 indexed citations
3.
Lefeuvre‐Plesse, Claudia, Carole Hélissey, Franck Priou, et al.. (2021). 1680P Feasibility of home-based supervised physical activity (SPA) for metastatic cancer patients receiving oral targeted therapy: The AFSOS-Unicancer QUALIOR randomized phase II study. Annals of Oncology. 32. S1178–S1178. 2 indexed citations
4.
Robert, Marie, Jean‐Sébastien Frenel, Emmanuelle Bourbouloux, et al.. (2018). Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer. Expert Opinion on Drug Metabolism & Toxicology. 15(2). 85–91. 8 indexed citations
5.
6.
Frenel, Jean‐Sébastien, Emmanuelle Bourbouloux, Dominique Berton-Rigaud, et al.. (2016). Place du trastuzumab emtansine dans le traitement systémique des métastases cérébrales du cancer du sein HER2+ : à propos de 5 cas et revue de la littérature. Bulletin du Cancer. 103(5). 507–510. 1 indexed citations
7.
Chapelet, Guillaume, Gilles Berrut, Emmanuelle Bourbouloux, et al.. (2015). Cancer screening practices in elderly with dementia. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 13(2). 133–140. 2 indexed citations
8.
Bourgeois, Hugues, Philippe Solal‐Céligny, Olivier Capitain, et al.. (2014). Assessing 2-month clinical prognosis in patients with solid tumors: Final results of PRONOPALL study.. Journal of Clinical Oncology. 32(15_suppl). 9558–9558. 1 indexed citations
9.
Raimbaud, Isabelle, Immanuel F. Luescher, Danijel Dojcinovic, et al.. (2011). NY-ESO-1-Specific Circulating CD4+ T Cells in Ovarian Cancer Patients Are Prevalently TH1 Type Cells Undetectable in the CD25+FOXP3+Treg Compartment. PLoS ONE. 6(7). e22845–e22845. 10 indexed citations
10.
Campone, Mario, Nicolás Isambert, Emmanuelle Bourbouloux, et al.. (2011). A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Cancer Chemotherapy and Pharmacology. 69(4). 871–879. 10 indexed citations
11.
Frenel, Jean‐Sébastien, Christophe Leux, Gwénaël Ferron, et al.. (2010). Oxaliplatin‐based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients. Journal of Surgical Oncology. 103(1). 10–16. 34 indexed citations
12.
Pallardy, Amandine, Caroline Bodet‐Milin, A. Oudoux, et al.. (2010). Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 37(7). 1270–1278. 27 indexed citations
13.
Brain, Étienne, C. Mertens, Véronique Girre, et al.. (2010). Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial. Critical Reviews in Oncology/Hematology. 80(1). 160–170. 38 indexed citations
14.
Campone, M., Vincent Lévy, Emmanuelle Bourbouloux, et al.. (2009). Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours. British Journal of Cancer. 100(2). 315–321. 74 indexed citations
15.
Isambert, Nicolás, Mario Campone, Emmanuelle Bourbouloux, et al.. (2009). Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours. European Journal of Cancer. 46(4). 729–734. 35 indexed citations
16.
Frenel, Jean‐Sébastien, et al.. (2009). Lapatinib in Metastatic Breast Cancer. Women s Health. 5(6). 603–612. 8 indexed citations
17.
Loussouarn, Delphine, L. Campion, Christine Sagan, et al.. (2008). Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas. British Journal of Cancer. 98(12). 1993–1998. 67 indexed citations
18.
Graveleau, J., Emmanuelle Bourbouloux, B. Bridji, et al.. (2007). A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET. Gynecologic Oncology. 105(2). 545–547. 6 indexed citations
19.
20.
Campone, Mario, P. Fumoleau, Emmanuelle Bourbouloux, Pierre Kerbrat, & Henri Roché. (2005). Taxanes in adjuvant breast cancer setting: Which standard in Europe?. Critical Reviews in Oncology/Hematology. 55(3). 167–175. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Johannes Battista Breakdown of academic impact, for papers by Toshiaki Saeki Breakdown of academic impact, for papers by Martin Zweifel Breakdown of academic impact, for papers by André T. Brunetto Breakdown of academic impact, for papers by Jolanta Krajewska Breakdown of academic impact, for papers by Zhong‐Ling Qiu Breakdown of academic impact, for papers by Martin Werner Breakdown of academic impact, for papers by R. Molina Breakdown of academic impact, for papers by Laura Pizzuti Breakdown of academic impact, for papers by M de Latour
Rankless by CCL
2026